Skip to main content
Cube Labs S.p.A. logo

Cube Labs S.p.A. — Investor Relations & Filings

Ticker · CUBE ISIN · IT0005532483 LEI · 815600566D45248BEB28 XMIL Professional, scientific and technical activities
Open in API
Filings indexed 131 across all filing types
Latest filing 2024-12-17 Capital/Financing Update
Country IT Italy
Listing XMIL CUBE

About Cube Labs S.p.A.

https://cube-labs.com/

Cube Labs S.p.A. is a venture builder specializing in the healthcare technology and life sciences sectors. The company's model focuses on identifying promising academic research and development and transforming it into commercial enterprises. It creates and nurtures startups to bridge the gap between scientific discovery and market-ready healthcare solutions. The firm's investment and development activities cover key areas including pharmaceuticals, biotechnology, medical technology (MedTech), nutraceuticals, and the application of artificial intelligence in R&D. A core part of its mission is to make research, technologies, and tools more accessible, fostering open innovation and collaboration to accelerate the development of new healthcare technologies.

Recent filings

Filing Released Lang Actions
PERFEZIONATA SOTTOSCRIZIONE DI ULTERIORI N° 140.000 AZIONI NELL’AMBITO DELL’AUMENTO DI CAPITALE IN CORSO PER UN CONTROVALORE COMPLESSIVO DI EURO 308.000,00
Capital/Financing Update Classification · 98% confidence The document is titled 'Comunicato Stampa' (Press Release) and details the completion of a subscription for new shares as part of an ongoing capital increase ('AUMENTO DI CAPITALE IN CORSO') and the sale of treasury shares. This clearly relates to financing activities and capital structure changes. The key subject matter aligns directly with the definition of 'Capital/Financing Update' (Code: CAP). Although it is a press release, the content is substantive regarding capital changes, making CAP more specific than a general RPA or RNS. The document length (9384 chars) suggests it is the primary announcement, not just a notification that a report is attached (which would favor RPA/RNS).
2024-12-17 Italian
CUBE LABS: LA STARTUP CONTROLLATA HIPERFORMING RESEARCH SIGLA CON B4 S.R.L. UN ACCORDO DI COLLABORAZIONE COMMERCIALE E LICENZA D’USO
Regulatory Filings Classification · 99% confidence The document is titled 'Comunicato Stampa' (Press Release) and announces a commercial collaboration and licensing agreement between Cube Labs' controlled startup, Hiperforming Research, and B4 S.r.l. It is dated November 19, 2024, and is classified as 'Informazione Regolamentata' (Regulated Information) on Euronext Growth Milan. This type of announcement, detailing a significant business development (a contract signing), is typically classified as a general regulatory announcement or a specific business update. Since there is no specific code for 'Business Development Announcement' and it is not a formal financial report (10-K, IR, ER), nor a management change (MANG) or dividend notice (DIV), it falls best under the general regulatory/miscellaneous category, which is RNS (Regulatory Filings). It is not an announcement *about* a report (RPA), but the report itself (a press release detailing an event).
2024-11-19 Italian
CUBE LABS: AGGIORNAMENTO SU IMPEGNO DI SOTTOSCRIZIONE VINCOLANTE DI EURO 150.000 DA PARTE DI INVESTITORE ISTITUZIONALE
Capital/Financing Update Classification · 99% confidence The document is a formal press release ('Comunicato Stampa') from CUBE LABS, identified by the 'Informazione Regolamentata' header and the filing number (20282-43-2024). The subject ('Oggetto') explicitly discusses an update regarding a binding subscription commitment (€150,000) related to a previously approved capital increase ('aumento di capitale'). This content directly relates to fundraising, financing activities, and capital structure changes. Therefore, the most appropriate classification is Capital/Financing Update (CAP). Although it is a press release, the core subject matter is financing, which is more specific than the general Regulatory Filing (RNS) or Report Publication Announcement (RPA) fallback categories.
2024-11-07 Italian
WARRANT CUBE LABS 2023 – 2025 RISULTATI DEL SECONDO PERIODO DI ESERCIZIO 7-18 OTTOBRE 2024
Regulatory Filings Classification · 95% confidence The document is an official communication from Cube Labs S.p.A. titled "WARRANT CUBE LABS 2023 – 2025 RISULTATI DEL SECONDO PERIODO DI ESERCIZIO 7-18 OTTOBRE 2024" (Results of the Second Exercise Period). It reports on the outcome of warrant exercises, stating that no warrants were exercised and the share capital remains unchanged. This type of announcement, detailing the results of a specific corporate action (warrant exercise) and its impact on capital structure, fits best under Capital/Financing Update (CAP) or potentially a general Regulatory Filing (RNS) if no other category is precise enough. Since it directly concerns the status of issued financial instruments (Warrants) and their effect on capital, CAP is the most appropriate specific category. The document is short and functions as a formal announcement of results, not the underlying detailed financing agreement itself.
2024-10-18 Italian
APERTURA DEL SECONDO PERIODO DI ESERCIZIO “WARRANT CUBE LABS 2023 – 2025”
Share Issue/Capital Change Classification · 99% confidence The document is an official notification from Cube Labs S.p.A. published on Euronext Growth Milan. The subject ('Oggetto') and headline clearly state: 'APERTURA DEL SECONDO PERIODO DI ESERCIZIO "WARRANT CUBE LABS 2023 – 2025"' (Opening of the second exercise period for 'Cube Labs 2023 – 2025 Warrants'). This announcement details the terms (price, dates) for exercising warrants to subscribe for new shares. This relates directly to changes in the company's capital structure or financing instruments. Among the provided codes, 'Capital/Financing Update' (CAP) is the most appropriate fit, as warrant exercise is a form of capital raising/structure adjustment. It is not a full report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), but a specific announcement about a financing mechanism.
2024-10-04 Italian
CUBE LABS: VENDITA DI 30.000 AZIONI PROPRIE IN PORTAFOGLIO DELLA SOCIETÀ
Transaction in Own Shares Classification · 98% confidence The document is an official regulatory announcement (Informazione Regolamentata) from CUBE LABS dated October 2, 2024. The subject ('Oggetto') is the 'VENDITA DI 30.000 AZIONI PROPRIE IN PORTAFOGLIO DELLA SOCIETÀ' (Sale of 30,000 own shares in the company's portfolio). This action—the company buying back or selling its own shares—directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a press release, the core content is a specific transaction type that fits POS better than the general 'RPA' or 'RNS'. The document details the number of shares sold, the price, and the resulting holding, confirming it is a report of the transaction itself, not just an announcement of a report.
2024-10-02 Italian

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.